Your browser doesn't support javascript.
loading
Chemosensitivity of mdr1 gene overexpressed multidrug resistant cancer cells to lidamycin / 药学学报
Yao Xue Xue Bao ; (12): 1146-1151, 2006.
Article de Zh | WPRIM | ID: wpr-294873
Bibliothèque responsable: WPRO
ABSTRACT
<p><b>AIM</b>To investigate the chemosensitivity to lidamycin (C-1027) in mdr1 gene overexpressing cancer cell lines established by drug induction and by gene-transfection.</p><p><b>METHODS</b>DNA was cloned by RT-PCR and then eukaryotic expressing recombinant plasmid pcDNA3. 1/mdrl was constructed. Using Lipofectamine 2000, a strain of stably transfected human hepatoma cancer cells, HepG2/mdrl, was obtained. The mdr1 mRNA level, P-glycoprotein (P-gp) level and the activity of P-gp to extrude drugs in cancer cells were determined by RT-PCR, immunofluorescence analysis and rhodamine 123 efflux assay. The chemosensitivity of cancer cells with low or high mdr1 expression to lidamycin and other antitumor drugs was tested by MTT assay.</p><p><b>RESULTS</b>The mdr1 mRNA and P-gp levels in KBv200, MCF-7/ADR, and stably transfected HepG2/mdr1 cells were much higher than that in respective parent KB, MCF-7 and HepG2 cells. The IC50 values of lidamycin for KBv200, MCF-7/ADR and HepG2/mdrl cells were (0.24 +/- 0.20) nmol x L(-1), (0.028 +/- 0.011) nmol x L(-1), and (0.020 +/- 0.011) nmol x L(-1), respectively. Compared with parental cells, the values of resistant fold for KBv200, MCF-7/ADR and HepG2/mdr1 cells to lidamycin were 6.8, 1.6 and 1.3 fold; to adriamycin were 37.2, 181.3 and 8.8 fold; to taxol were 336.8, 49.2 and 40.3 fold, respectively.</p><p><b>CONCLUSION</b>Lidamycin is highly active to multidrug resistant cancer cells. The chemosensitivity of those resistant cancer cells to lidamycin is approximately at the similar level as that of parent cancer cells.</p>
Sujet(s)
Texte intégral: 1 Indice: WPRIM Sujet Principal: Anatomopathologie / Pharmacologie / Transfection / Glycoprotéine P / Multirésistance aux médicaments / Résistance aux médicaments antinéoplasiques / Gènes MDR / Lignée cellulaire tumorale / Traitement médicamenteux / Ènediynes Limites du sujet: Humans langue: Zh Texte intégral: Yao Xue Xue Bao Année: 2006 Type: Article
Texte intégral: 1 Indice: WPRIM Sujet Principal: Anatomopathologie / Pharmacologie / Transfection / Glycoprotéine P / Multirésistance aux médicaments / Résistance aux médicaments antinéoplasiques / Gènes MDR / Lignée cellulaire tumorale / Traitement médicamenteux / Ènediynes Limites du sujet: Humans langue: Zh Texte intégral: Yao Xue Xue Bao Année: 2006 Type: Article